I agree that this site is using cookies. You can find further informations here.
X
Rosti, G.
350  results:
Search for persons X
?
1

P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:

Apperley, J. ; Kantarjian, H. ; Deininger, M....
HemaSphere.  6 (2022)  - p. 602-603 , 2022
Link: https://doi.org/10.1097/..
 
?
2

P719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER-LINE PATIEN..:

Gambacorti-Passerini, C. ; Brümmendorf, T. H. ; Ernst, T....
HemaSphere.  6 (2022)  - p. 614-615 , 2022
Link: https://doi.org/10.1097/..
 
?
3

S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILIT..:

Mancini, M. ; De Santis, S. ; Monaldi, C....
HemaSphere.  6 (2022)  - p. 53-54 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REP..:

Efficace, F. ; Cottone, F. ; Yanez, B....
HemaSphere.  6 (2022)  - p. 1587-1588 , 2022
Link: https://doi.org/10.1097/..
 
?
5

S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB ..:

Pane, F. ; Castagnetti, F. ; Luciano, L....
HemaSphere.  6 (2022)  - p. 57-58 , 2022
Link: https://doi.org/10.1097/..
 
?
6

European LeukemiaNet 2020 recommendations for treating chro..:

Hochhaus, A. ; Baccarani, M. ; Silver, R. T....
Leukemia.  34 (2020)  4 - p. 966-984 , 2020
Link: https://doi.org/10.1038/..
 
?
7

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM..:

Mancini, M. ; De Santis, S. ; Monaldi, C....
Journal of Experimental & Clinical Cancer Research.  38 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
8

Administration of high-dose chemotherapy with stem cell sup..:

Necchi, A ; Lo Vullo, S ; Rosti, G...
Bone Marrow Transplantation.  52 (2017)  8 - p. 1218-1220 , 2017
Link: https://doi.org/10.1038/..
 
?
9

Incidence of secondary malignancies (SM) in patients (pts) ..:

Necchi, A. ; Rosti, G. ; Badoglio, M....
European Urology Supplements.  16 (2017)  3 - p. e1909 , 2017
Link: https://doi.org/10.1016/..
 
?
10

European LeukemiaNet recommendations for the management and..:

Steegmann, J L ; Baccarani, M ; Breccia, M...
Leukemia.  30 (2016)  8 - p. 1648-1671 , 2016
Link: https://doi.org/10.1038/..
 
?
11

Treatment and outcome of 2904 CML patients from the EUTOS p..:

Hoffmann, V S ; Baccarani, M ; Hasford, J...
Leukemia.  31 (2016)  3 - p. 593-601 , 2016
Link: https://doi.org/10.1038/..
 
?
12

2924 Time to response (TTR) and early tumor shrinkage (ETS)..:

Franceschi, E. ; Finocchiaro, G. ; Zagonel, V....
European Journal of Cancer.  51 (2015)  - p. S592 , 2015
Link: https://doi.org/10.1016/..
 
?
13

High-Dose Chemotherapy With Autologous Hematopoietic Stem C..:

Pedrazzoli, P. ; Martino, M. ; Delfanti, S....
JNCI Monographs.  2015 (2015)  51 - p. 70-75 , 2015
Link: https://doi.org/10.1093/..
 
?
14

Frontline nilotinib in patients with chronic myeloid leukem..:

Hochhaus, A ; Rosti, G ; Cross, N C P...
Leukemia.  30 (2015)  1 - p. 57-64 , 2015
Link: https://doi.org/10.1038/..
 
?
15

The impact of comorbidity on health-related quality of life..:

Efficace, F. ; Rosti, G. ; Breccia, M....
Annals of Hematology.  95 (2015)  2 - p. 211-219 , 2015
Link: https://doi.org/10.1007/..
 
1-15